Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 3
2010 4
2011 4
2012 14
2013 27
2014 20
2015 15
2016 14
2017 5
2018 5
2019 2
2021 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 25214194

97 results
Results by year
Filters applied: . Clear all
Page 1
COMPLEMENTing the diagnosis of aHUS.
Afshar-Kharghan V. Afshar-Kharghan V. Blood. 2014 Sep 11;124(11):1699-700. doi: 10.1182/blood-2014-07-590356. Blood. 2014. PMID: 25214194 Free PMC article.
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy.
Noris M, Galbusera M, Gastoldi S, Macor P, Banterla F, Bresin E, Tripodo C, Bettoni S, Donadelli R, Valoti E, Tedesco F, Amore A, Coppo R, Ruggenenti P, Gotti E, Remuzzi G. Noris M, et al. Blood. 2014 Sep 11;124(11):1715-26. doi: 10.1182/blood-2014-02-558296. Epub 2014 Jul 18. Blood. 2014. PMID: 25037630 Free PMC article. Clinical Trial.
Eculizumab as rescue therapy for atypical hemolytic uremic syndrome with normal platelet count.
Dorresteijn EM, van de Kar NC, Cransberg K. Dorresteijn EM, et al. Pediatr Nephrol. 2012 Jul;27(7):1193-5. doi: 10.1007/s00467-012-2130-z. Epub 2012 Mar 8. Pediatr Nephrol. 2012. PMID: 22399074 Free PMC article.
Complement inhibitor eculizumab in atypical hemolytic uremic syndrome.
Mache CJ, Acham-Roschitz B, Frémeaux-Bacchi V, Kirschfink M, Zipfel PF, Roedl S, Vester U, Ring E. Mache CJ, et al. Clin J Am Soc Nephrol. 2009 Aug;4(8):1312-6. doi: 10.2215/CJN.01090209. Epub 2009 Jun 25. Clin J Am Soc Nephrol. 2009. PMID: 19556379 Free PMC article.
Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
Besbas N, Gulhan B, Karpman D, Topaloglu R, Duzova A, Korkmaz E, Ozaltin F. Besbas N, et al. Pediatr Nephrol. 2013 Jan;28(1):155-8. doi: 10.1007/s00467-012-2296-4. Epub 2012 Sep 6. Pediatr Nephrol. 2013. PMID: 22956028
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.
Zuber J, Fakhouri F, Roumenina LT, Loirat C, Frémeaux-Bacchi V; French Study Group for aHUS/C3G. Zuber J, et al. Nat Rev Nephrol. 2012 Nov;8(11):643-57. doi: 10.1038/nrneph.2012.214. Epub 2012 Oct 2. Nat Rev Nephrol. 2012. PMID: 23026949 Review.
Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab.
Gulleroglu K, Fidan K, Hançer VS, Bayrakci U, Baskin E, Soylemezoglu O. Gulleroglu K, et al. Pediatr Nephrol. 2013 May;28(5):827-30. doi: 10.1007/s00467-013-2416-9. Epub 2013 Feb 7. Pediatr Nephrol. 2013. PMID: 23389237
Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
Asif A, Nayer A, Haas CS. Asif A, et al. J Nephrol. 2017 Jun;30(3):347-362. doi: 10.1007/s40620-016-0357-7. Epub 2016 Nov 15. J Nephrol. 2017. PMID: 27848226 Free PMC article. Review.
Atypical hemolytic uremic syndrome.
Kavanagh D, Goodship TH. Kavanagh D, et al. Curr Opin Hematol. 2010 Sep;17(5):432-8. doi: 10.1097/MOH.0b013e32833cae86. Curr Opin Hematol. 2010. PMID: 20613506 Review.
Eculizumab as first-line therapy for atypical hemolytic uremic syndrome.
Christmann M, Hansen M, Bergmann C, Schwabe D, Brand J, Schneider W. Christmann M, et al. Pediatrics. 2014 Jun;133(6):e1759-63. doi: 10.1542/peds.2013-1787. Pediatrics. 2014. PMID: 24843059
97 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback